⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

A Brief Discussion About American Funds Europacific Growth A Fund (AEPGX)

Published 12/07/2016, 08:56 PM
Updated 07/09/2023, 06:31 AM
NOVOb
-

American Funds Europacific Growth A (AEPGX) a Zacks Rank #2 (Buy) normally invests at least 80% of assets in securities of issuers domiciled in Europe or the Pacific Basin. AEPGX invests primarily in common and preferred stocks, convertibles, American Depositary Receipts, European Depositary Receipts, bonds and cash. The objective of AEPGX is to seek long-term growth of capital by investing in companies based outside the United States. AEPGX was incepted in April 1984 and is managed by Capital Research and Management Company.

American Funds Europacific Growth A, managed by American Funds, carries an expense ratio of 0.83%. Moreover, AEPGX requires a minimal initial investment of $250.

AEPGX’s performance, as of the last filing, when compared to funds in its category was in the top 46% in 1 year, top 16% over the past 3 years, and in the 21% over the past 5 years.

This fund, as of the last filing, allocates their fund in four major groups; Foreign Stock, High Yield Bond and Emerging Market. Further, as of the last filing, Novo Nordisk (CO:NOVOb), Novartis and Tencent Holdings were the top holdings for AEPGX.

AEPGX has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 1, 3 and 5 year benchmarks; 1 year 0.1%, 3 year 1.04% and 5 year 6.25%. To see how this fund performed compared in its category and other #1 and #2 Ranked Mutual Funds, please click here.

About Zacks Mutual Fund Rank

By applying the Zacks Rank to mutual funds, investors can find funds that not only outpaced the market in the past but are also expected to outperform going forward. Pick the best mutual funds with the Zacks Rank.

Want key mutual fund info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>


View All Zacks #1 Ranked Mutual Funds

Get Your Free (AEPGX): Fund Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.